Investigational The leading clinical investigations in early-stage Hodgkin's disease are designed to decrease the toxicity of treatment without reducing the overall excellent results.
More effective therapy is needed for patients with very extensive disease and better chemotherapy programs are needed for the elderly. The use of hematopoietic growth factors is likely to improve treatment for both ( see Biological Therapy ). Current studies will eventually define the best use of intensive chemotherapy, radiation therapy and bone marrow transplantation.
